Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck
1 clinical trials · Condition
◉ Watch Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck
| Record | Firm | Date |
|---|---|---|
| Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck (NCT02558387) | Samsung Medical Center | 2014-11-01 |
Track Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck automatically
Every clearance here is in the API, with alerts when new ones post.